Ottobock sets standards
For more than 100 years, Ottobock develops innovative products. Meanwhile, the med-tech company also takes care of the full treatment cycle all over the globe. These services are provided under the Ottobock SE & Co. KGaA name, which began in 2018 to channel the company’s med-tech expertise also into sustainably healthy workplaces.
We continually develop our company and perfect our technology to improve the lives of our users. In 2019, we invested 9% of our turnover of product sales in research and development.
Since 1919 products and technologies from Ottobock have been helping people gain new freedom of movement and avoid potential complications. Initially, the company revolutionised the market – above all treatment for patients – thanks to the series production of prosthetic components. Since then, the focus has turned to microprocessor-controlled knee joints such as the C-Leg (which can be controlled via an app), the computer-controlled C-Brace leg orthosis, the multi-articulating bebionic hand, Juvo power wheelchairs and the Paexo exoskeleton range for ergonomic workplaces.
Our single-minded determination to improve quality of life has made us a global leader in technology for wearable human bionics, which enhance or replace parts of the human body.
Ottobock SE & Co. KGaA
- €1.003 million turnover in 2019
- Over 8,000 employees in more than 50 countries across the world
- More than 240 company-operated patient care centres
- Global market leader in prosthetics
Family-owned, with a strong market position
We are a modern, family-owned company which combines a love of progress with values we truly live by. More than 8,000 employees work for Ottobock SE & Co. KGaA and generate a turnover totaling a little over €1 billion.
Eighty per cent of Ottobock SE & Co. KGaA is owned by Näder Holding GmbH & Co. KG. This is the sole property of the owner family, the Näders, and therefore the direct descendants of Otto Bock, the company founder.
Backed by the right investor
In 2017 Swedish private equity firm EQT acquired a 20 per cent share in Ottobock SE & Co. KGaA. EQT helps us continue to grow in a sustainable and profitable manner. This will let us enhance our edge in the digitalisation of orthopaedic technology and tap into our full potential.
“Our strong performance in 2019 confirms that we’re on the right course for our future as a global leader for technology, offering top-notch devices and treatment. A whole century has passed since the company was founded by my grandfather, Otto Bock, but the company’s guiding principle has remained unchanged: quality of life and mobility for people with disabilities.”
Professor Hans Georg Näder, Chairman of the Board
Products and services from Ottobock
Closed loop for optimum treatment
We take a holistic approach to treatment so people can enjoy the best possible quality of life. From the initial consultation through to taking measurements, fitting the device and rehabilitation – we offer guidance and support, and develop custom solutions.
In our Ottobock Academy we also offer basic and advanced training programmes for orthopaedic and rehabilitation technology. The Academy’s extensive programme is designed for the different groups of professionals who are involved in the treatment process. In cooperation with the PFH Private University of Applied Sciences in Göttingen, the University of Göttingen and other partners, Ottobock has developed courses of study in the fields of orthobionics and healthcare technology.